Main Street Group
LFCR icon

Main Street Group’s Lifecore Biomedical LFCR Stock Holding History

Main Street Group’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.37K Buy
208
+108
+108% +$501 ﹤0.01% 769
2026
Q2 		$525 Buy
+100
New +$504 ﹤0.01% 777

Other funds holding LFCR

DA
DCF Advisers Greenwich, Connecticut $444M AUM 151.5% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
CWC Advisors
CWC Advisors Lake Oswego, Oregon $215M AUM 18.92% 1-Year Est. Return
MAA
Mraz Amerine & Associates Modesto, California $640M AUM 12.53% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Covestor
Covestor London, United Kingdom $157M AUM 35.87% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Pinnacle Wealth Planning Services
Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Equitec Proprietary Markets
Equitec Proprietary Markets Chicago, Illinois $400M AUM 66.98% 1-Year Est. Return

Main Street Group's LFCR Position: Q3 2026 in Review

Main Street Group increased its Lifecore Biomedical (LFCR) stake by 108% in Q3 2026, buying an estimated $501 and bringing the position to 208 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #769.

Main Street Group first reported a position in LFCR in Q2 2026 and has held it in 2 quarters since. 24 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.

  • Main Street Group held 208 shares of Lifecore Biomedical worth $1.37K as of Q3 2026.
  • Main Street Group bought 108 Lifecore Biomedical shares in Q3 2026, an estimated $501.
  • Lifecore Biomedical made up ﹤0.01% of Main Street Group's portfolio in Q3 2026, its #769 holding.
  • Main Street Group first reported a position in Lifecore Biomedical in Q2 2026 and has held it in 2 quarters since.
  • 24 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.

Based on Main Street Group's 13F filing for Q3 2026, filed 28 Oct 2026.